MedTrace Logo

Pro-Change Smoking Cessation Intervention

NCT02299076 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 422

Last updated 2017-10-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether a behavioral economics solution impacts smoking cessation program engagement and quit rates.

Conditions

  • Tobacco Smoking Cessation
  • Motivation

Interventions

BEHAVIORAL

Behavioral economics incentives

Behavioral economics-informed incentives to promote engagement and outcomes in a smoking cessation intervention.

OTHER

Minimal incentives

Minimal financial incentives to promote engagement and outcomes in a smoking cessation intervention.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Rhode Island Primary Care Physicians Corporation

    collaborator UNKNOWN

  • Pro-Change Behavior Systems

    collaborator OTHER

  • VAL Health, LLC

    lead INDUSTRY

Principal Investigators

  • Karen Horgan, MBA · President

  • Kevin Volpp, MD, PhD · Scientific Advisory Board

  • David Asch, MD · Scientific Advisory Board

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2016-07-01
Completion
2016-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02299076 on ClinicalTrials.gov